Sciencast Management’s Imperva, Inc. IMPV Stock Holding History

Sciencast Management’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,600	Closed	-$241K	–	307
2016 Q2	$241K	Buy	+5,600	New	+$235K	0.11%	239

Other funds holding IMPV

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Litespeed Management New York $48.2M AUM 9.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EPCM

Eton Park Capital Management New York $2.28B AUM 33.59% 1-Year Est. Return

Sciencast Management's IMPV Position: Q3 2016 in Review

Sciencast Management sold out of Imperva, Inc. (IMPV) in Q3 2016, closing a stake of 5,600 shares — an estimated $241K sold.

Sciencast Management first reported a position in IMPV in Q2 2016 and held it in 1 quarter. The position peaked at $241K in Q2 2016. 187 funds tracked by Wall St. Rank hold IMPV as of Q3 2016.

Sciencast Management reported no remaining Imperva, Inc. position as of Q3 2016 after selling out during the quarter.
Sciencast Management sold 5,600 Imperva, Inc. shares in Q3 2016, an estimated $241K.
Sciencast Management first reported a position in Imperva, Inc. in Q2 2016 and held it in 1 quarter.
Sciencast Management's Imperva, Inc. position peaked at $241K in Q2 2016.
187 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2016.

Based on Sciencast Management's 13F filing for Q3 2016, filed 14 Nov 2016.